Novel extended-spectrum β-lactamase in Shigella sonnei [5]

Emerging Infectious Diseases

Volumn 13, Issue 4, 2007, Pages 653-654

  Lefort, Agnes ^a,b,d   Arlet, Guillaume ^c   Join Lambert, Olivier F ^a,b   Lecuit, Marc ^a,b   Lortholary, Olivier ^a,b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Centre d'Infectiologie Necker Pasteur   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BETA LACTAMASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANAMNESIS; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; CASE REPORT; CLINICAL FEATURE; GASTROENTERITIS; HUMAN; LETTER; MALE; SHIGELLA SONNEI; SHIGELLOSIS;

EID: 34047186942     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1304.061160     Document Type: Letter

References (10)

1. Jain SK, Gupta A, Glanz B, Dick J, Siberry GK. Antimicrobial-resistant Shigella sonnei: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility. Pediatr Infect Dis J. 2005;24:494-7.
2. Khan WA, Seas C, Dhar U, Salam MA, Bennish ML. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Ann Intern Med. 1997;126:697-703.
3. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, et al. Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother. 2004;48: 1249-55.
4. Radice M, Gonzealez C, Power P, Vidal MC, Gutkind G. Third-generation cephalosporin resistance in Shigella sonnei, Argentina. Emerg Infect Dis. 2001;7:442-3.
5. Kim S, Kim J, Kang Y, Park Y, Lee B. Occurrence of extended-spectrum betalactamases in members of the genus Shigella in the republic of Korea. J Clin Microbiol. 2004;42:5264-9.
6. Lee K, Yong D, Yum JH, Kim HH, Chong Y. Diversity of TEM-52 extended-spectrum β-lactamase-producing nontyphoidal Salmonella isolates in Korea. J Antimicrob Chemother. 2003;52:493-6.
7. Yong D, Lim YS, Yum JH, Lee H, Lee K, Kim EC, et al. Nosocomial outbreak of pediatric gastroenteritis caused by CTXM-14-type extended-spectrum β-lactamase-producing strains of Salmonella enterica serovar London. J Clin Microbiol. 2005;43:3519-21.
8. Acikgoz ZC, Gulay Z, Bicmen M, Gocer S, Gamberzade S. CTX-M-3 extendedspectrum beta-lactamase in a Shigella sonnei clinical isolate: first report from Turkey. Scand J Infect Dis. 2003;35: 503-5.
9. Cheung TK, Chu YW, Tsang GK, Ngang JY, Hui IS, Kam KS. Emergence of CTXM-type beta-lactam resistance in Shigella spp. in Hong Kong. Int J Antimicrob Agents. 2005;25:350-2.
10. Rahman M, Shoma S, Rashid H, Siddique AK, Nair GB, Sack DA. Extended-spectrum beta-lactamase-mediated third-generation cephalosporin resistance in Shigella isolates in Bangladesh. J Antimicrob Chemother. 2004;54:846-7.